| Variables . | Day 30 eGFR, mL/min/1.73m² . | Multivariate analysis . | |
|---|---|---|---|
| β ± standard error . | P-value . | ||
| IAH grade | 0.05 | ||
| 0–1–2 (n = 38) | 52.5 ± 21.3 | 1 | |
| 3–4 (n = 17) | 35.8 ± 18.8 | −10.3 ± 5.3 | |
| Donor:recipient height ratio | 78.8 ± 32.8 | 0.02 | |
| Donor:recipient BMI ratio | 31.2 ± 9.1 | 0.001 | |
| Donor type | 0.0006 | ||
| Living (n = 6) | 67.3 ± 19.2 | 27.5 ± 7.5 | |
| Deceased (n = 49) | 44.9 ± 21.1 | 1 | |
| Non-DSA anti-HLA previous immunization | 0.03 | ||
| Yes (n = 23) | 54.3 ± 25.4 | 10.9 ± 4.8 | |
| No (n = 32) | 42.3 ± 17.6 | 1 | |
| Variables . | Day 30 eGFR, mL/min/1.73m² . | Multivariate analysis . | |
|---|---|---|---|
| β ± standard error . | P-value . | ||
| IAH grade | 0.05 | ||
| 0–1–2 (n = 38) | 52.5 ± 21.3 | 1 | |
| 3–4 (n = 17) | 35.8 ± 18.8 | −10.3 ± 5.3 | |
| Donor:recipient height ratio | 78.8 ± 32.8 | 0.02 | |
| Donor:recipient BMI ratio | 31.2 ± 9.1 | 0.001 | |
| Donor type | 0.0006 | ||
| Living (n = 6) | 67.3 ± 19.2 | 27.5 ± 7.5 | |
| Deceased (n = 49) | 44.9 ± 21.1 | 1 | |
| Non-DSA anti-HLA previous immunization | 0.03 | ||
| Yes (n = 23) | 54.3 ± 25.4 | 10.9 ± 4.8 | |
| No (n = 32) | 42.3 ± 17.6 | 1 | |
Values are reported as mean ± SD. DSA: donor-specific antigen antibodies.
| Variables . | Day 30 eGFR, mL/min/1.73m² . | Multivariate analysis . | |
|---|---|---|---|
| β ± standard error . | P-value . | ||
| IAH grade | 0.05 | ||
| 0–1–2 (n = 38) | 52.5 ± 21.3 | 1 | |
| 3–4 (n = 17) | 35.8 ± 18.8 | −10.3 ± 5.3 | |
| Donor:recipient height ratio | 78.8 ± 32.8 | 0.02 | |
| Donor:recipient BMI ratio | 31.2 ± 9.1 | 0.001 | |
| Donor type | 0.0006 | ||
| Living (n = 6) | 67.3 ± 19.2 | 27.5 ± 7.5 | |
| Deceased (n = 49) | 44.9 ± 21.1 | 1 | |
| Non-DSA anti-HLA previous immunization | 0.03 | ||
| Yes (n = 23) | 54.3 ± 25.4 | 10.9 ± 4.8 | |
| No (n = 32) | 42.3 ± 17.6 | 1 | |
| Variables . | Day 30 eGFR, mL/min/1.73m² . | Multivariate analysis . | |
|---|---|---|---|
| β ± standard error . | P-value . | ||
| IAH grade | 0.05 | ||
| 0–1–2 (n = 38) | 52.5 ± 21.3 | 1 | |
| 3–4 (n = 17) | 35.8 ± 18.8 | −10.3 ± 5.3 | |
| Donor:recipient height ratio | 78.8 ± 32.8 | 0.02 | |
| Donor:recipient BMI ratio | 31.2 ± 9.1 | 0.001 | |
| Donor type | 0.0006 | ||
| Living (n = 6) | 67.3 ± 19.2 | 27.5 ± 7.5 | |
| Deceased (n = 49) | 44.9 ± 21.1 | 1 | |
| Non-DSA anti-HLA previous immunization | 0.03 | ||
| Yes (n = 23) | 54.3 ± 25.4 | 10.9 ± 4.8 | |
| No (n = 32) | 42.3 ± 17.6 | 1 | |
Values are reported as mean ± SD. DSA: donor-specific antigen antibodies.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
